Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLOBE-4 liraglutide study in obesity among adults with and without HIV in South Africa
PACTR202610839417053Phase 4Not yet recruiting
- Sponsor
- Africa Health Research Institute
- Start
- May 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of liraglutide in obesity and human immunodeficiency virus infection (HIV) (2 arms), sponsored by Africa Health Research Institute. Planned start May 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesityhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202610839417053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610839417053.